Adaptation of controlled attenuation parameter (CAP) measurement depth in morbidly obese patients addressed for bariatric surgery

BACKGROUND AND AIM: The controlled attenuation parameter (CAP) using FibroScan (Echosens, Paris, France) M or XL probe has been developed for liver steatosis assessment. However, CAP performs poorly in patients with high body mass index. The aim of our study was to assess whether CAP is overestimate...

Descripción completa

Detalles Bibliográficos
Autores principales: Somda, Sosthene, Lebrun, Amandine, Tranchart, Hadrien, Lamouri, Karima, Prevot, Sophie, Njike-Nakseu, Micheline, Gaillard, Martin, Lainas, Panagiotis, Balian, Axel, Dagher, Ibrahim, Perlemuter, Gabriel, Naveau, Sylvie, Voican, Cosmin Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534321/
https://www.ncbi.nlm.nih.gov/pubmed/31125357
http://dx.doi.org/10.1371/journal.pone.0217093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534321/
https://www.ncbi.nlm.nih.gov/pubmed/31125357
http://dx.doi.org/10.1371/journal.pone.0217093

Ejemplares similares